Viewing Protocol Section

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

eRecord

Main Search All Studies All Organizations Report Bug

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT04433546

Ignite Creation Date: 2024-05-06 @ 2:49 PM

Last Modification Date: 2024-10-26 @ 1:37 PM

Study NCT ID: NCT04433546

Protocol Section: NCT04433546

Start Identification Module Data

Expand Identification Module Data

Brief Title: Pemziviptadil PB1046 a Long-acting Sustained Release Human VIP Analogue Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome ARDS

Official Title: A Randomized Double-Blind Parallel Group Study to Assess the Efficacy and Safety of Once Weekly Subcutaneous Injections of Pemziviptadil PB1046 a Sustained-Release VIP Vasoactive Intestinal Peptide ANalogue in Hospitalized COVID-19 Patients at HiGh Risk for Rapid Clinical Deterioration and ARDS PB1046 VANGARD Study

Acronym: VANGARD

Organization: PhaseBio Pharmaceuticals Inc

Organization Class: INDUSTRY

Organization Study ID: PB1046-PT-CL-0007

Start Status Module Data

Status Verified Date: 2020-12

Overall Status: TERMINATED

Study First Submit Date:

Study First Submit QC Date:

Last Update Submit Date:

Status:

Start Sponsor Collaborators Module Data

Investigator:

Lead Sponsor: PhaseBio Pharmaceuticals Inc

Lead Sponsor Class: INDUSTRY

Lead Sponsor: PhaseBio Pharmaceuticals Inc

Start Oversight Module Data

Description Module:

Study Last Update Post Date Type(Status Module):

Attachment: Upload